ESC 365 - Troponin/creatine kinase ratio for discrimination of type 1 and type 2 myocardial infarction

ESC Professional Premium Access

Troponin/creatine kinase ratio for discrimination of type 1 and type 2 myocardial infarction

Session: High-sensitivity cardiac troponin assays: integrating evidence from clinical trials and implementation studies

Topic: Biomarkers

Speaker: Doctor J. Lehmacher (Hamburg, DE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Jonas Lehmacher

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

0 follower

4 more presentations in this session

Rapid rule-out of acute myocardial infarction using the 0/1-hour algorithm for cardiac troponins in emergency primary care: the OUT-ACS implementation study.

Speaker: Doctor T. Johannessen (Oslo, NO)

Clinical and experimental evidence for differences between cardiac troponin I and T in acute and chronic cardiovascular conditions

Speaker: Doctor T. Zimmermann (Basel, CH)

Serial troponin sampling over 60-minutes allows early distinction between myocardial infarction and chronic myocardial injury in patients presenting to emergency departments.

Speaker: Miss G. Vimalaratnam (AU)

Acute kidney injury in relation to high-sensitivity cardiac troponin T levels in the emergency department

Speaker: Doctor L. Cyon (Stockholm, SE)

Access the full session

High-sensitivity cardiac troponin assays: integrating evidence from clinical trials and implementation studies

Speakers: Doctor J. Lehmacher, Doctor T. Johannessen, Doctor T. Zimmermann, Miss G. Vimalaratnam, Doctor L. Cyon

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources